O-51: Overexpression of the MAT-1 oncogene in non-insulin-dependent diabetes
Gerolama Condorelli(Institute for Experimental Endocrinology and Oncology), Francesco Bèguinot(University of Naples Federico II), Giuseppe Alessandro Parasiliti Palumbo(University of Catania), Agnese Caiola, Elvira Crescenzi(Institute for Experimental Endocrinology and Oncology), Carlo G. Tocchetti(Federico II University Hospital), Giovanni Vigliottá(University of Salerno), Francesco Andreozzi(Magna Graecia University), Mario Felice Tecce(Angiologica (Italy))
Cited by 0
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
|Frontiers in Physiology|2020|1.1k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
|The Journal of Experimental Medicine|1994|591